Generics

Filter

Current filters:

None

Popular Filters

1126 to 1150 of 1179 results

New low cost HIV drug to be made by Ugandan company

09-02-2012

Starting as early as next month, Uganda will produce a new low cost and more effective life saving HIV/AIDS…

Anti-viralsGenericsMarkets & MarketingRest of the WorldTenofovir Disoproxil Fumarate

Generics will drive Australia’s PBS saving in 2012, says GMiA

09-02-2012

Australian patients and taxpayers need to make the most of the unprecedented value of medicines coming…

Asia-PacificFinancialGenericsHealthcare

Watson settles with Janssen over Ortho Tri-Cyclen LO

08-02-2012

US generic drugmaker Watson Pharmaceutical (NYSE: WPI) says that its subsidiary, Watson Laboratories,…

GenericsJanssenJohnson & JohnsonLegalNorth AmericaPatentsReproductiveWatson PharmaceuticalsWomen's Health

Sanofi fourth-quarter in line with forecasts; collects damages

08-02-2012

French drug major Sanofi (Euronext: SAN) this morning reported 8.8% growth in fourth-quarter 2011 sales…

ApotexBristol-Myers SquibbFinancialGenericsLegalPatentsPharmaceuticalPlavix

Zydus Cadila third-quarter revenues up 20%

07-02-2012

Indian drugmaker Zydus Cadila posted total revenue of 14.01 billion rupees ($287.7 million) for the third…

FinancialGenericsZydus Cadila

Shanghai Pharma aims to take control of Kony Pharma

07-02-2012

In a regulatory filing with the Hong Kong Stock Exchange yesterday, Shanghai Pharmaceuticals Holding…

Asia-PacificGenericsKony PharmaMergers & AcquisitionsShanghai Pharmaceutical Group

New bipartisan legislation to address US drug shortages

06-02-2012

US Representatives John Carney (Democrat, Delaware) and Larry Bucshon (Republican, Indian) last week…

GenericsLegalNorth AmericaPharmaceuticalRegulation

Dr Reddy’s beats forecasts, with 88% profits hike

06-02-2012

India drug major Dr Reddy’s Laboratories (500124: BO) saw its shares rise 2.2% to 1,670.50 rupees…

Dr Reddy's LaboratoriesFinancialGenerics

New Actavis/Bioton alliance aims to shake up diabetes market

31-01-2012

Icelandic generics drugmaker Actavis and Poland’s Bioton (WSE: BIO) have formed a joint venture…

ActavisBiotonDiabetesGenericsMarkets & MarketingMergers & AcquisitionsPharmaceutical

STADA and Grunenthal agree lower price for certain branded products

30-01-2012

German drugmakers STADA Arzneimittel (SAZ: GR) and family-owned Grunenthal have agreed on the purchase…

EuropeGenericsGrunenthalMergers & AcquisitionsSTADA Arzneimittel

EC and Italian government seek to boost generic medicine use

30-01-2012

The European Commission’s formal call last week on Italy to comply with European Union rules on…

EuropeGenericsMarkets & MarketingPatentsPharmaceuticalPoliticsRegulation

EC closes procedural case against Servier

29-01-2012

The European Commission said last Friday that it has closed an investigation into Fremch independent…

EuropeGenericsMarkets & MarketingPharmaceuticalRegulationServier

Department of Justice seeks permanent injunction against Ranbaxy

27-01-2012

The US Department of Justice, on behalf of the Food and Drug Administration, has filed a consent decree…

Asia-PacificGenericsLegalNorth AmericaRanbaxy LaboratoriesRegulation

Kenya court set to deliver ruling on anti-counterfeit law

27-01-2012

After almost three years of waiting since three petitioners living with HIV filed a constitutional petition…

GenericsLegalMarkets & MarketingPharmaceuticalRest of the World

Overview of biologic regulations in India

26-01-2012

Currently, all biologics in India, including innovative and copy biologics are approved as new drugs,…

Asia-PacificBiotechnologyGenericsRegulation

Actavis launches latanoprost generics in Europe

26-01-2012

Iceland-based generic drugmaker Actavis says that it has launched latanoprost eye drops in seven major…

ActavisEuropeGenericsLatanoprost OphthalmicMarkets & MarketingOphthalmicsPfizerXalatan

Watson buys Strides Arcolab unit for A$375 million; 2011 results

24-01-2012

US generic drugmaker Watson Pharmaceuticals (NYSE: WPI) has kicked off the new year with the acquisition…

Ascent PharmahealthAsia-PacificFinancialGenericsMergers & AcquisitionsStrides ArcolabWatson Pharmaceuticals

The Medicines Co settles with APP over Angiomax

24-01-2012

The Medicines Company (Nasdaq: MDCO) says that it has settled the law suits filed by company in the US…

AngiomaxAPP PharmaceuticalsCardio-vascularFresenius KabiGenericsLegalNorth AmericaPatentsPharmaceuticalThe Medicines Company

Significant advances in biosimilar medicines claimed for Iran

23-01-2012

Iran is making significant advances in medicine production, especially in the fields of biosimilar and…

BiotechnologyGenericsMarkets & MarketingRest of the World

EMA starts review of Gilenya; guidance on biosimilar interferon beta

23-01-2012

The European Medicines Agency has begun a review of the benefits and risks of Swiss drug major Novartis’…

BiotechnologyEuropeGenericsGilenyainterferon betaNeurologicalNovartisPharmaceuticalRegulation

1126 to 1150 of 1179 results

Back to top